Regional Lymph Node Basin (RLNB) Relapse after Adjuvant Ipilimumab (Ipi) Anti-CTLA4 Immunotherapy in Stage III Melanoma: A Subgroup Analysis of a Randomized Placebo-Controlled TrialChristopher A. Barker, Jedd D. Wolchok, Douglas B. Johnson et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 1